Reply to "Key Points to Consider When Evaluating Andexxa for Formulary Addition".

ABSTRACT:

SUBMITTER: Mahan CE 

PROVIDER: S-EPMC7392924 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature